Condition: Peritoneal Carcinomatosis · Colon Cancer · Sponsor: Hospital Universitario de Fuenlabrada
The aim of this study is to assess whether there are differences in PERITONEAL RECURRENCE in patients with Colon Cancer Peritoneal Metastases treated with complete surgical resection and systemic chemotherapy, with (Group 1) or without (Group 2) HIPEC with Mitomycin-C.
This description comes directly from the study's public registry record.
Fernando Pereira, PhD · +34916006455 · fernando.pereira@salud.madrid.org
Always discuss trial participation with your own doctor first.
| Hospital General Universitario de Elche | Elche, Alicante, Spain | Recruiting |
| Hospital Universitario Torrecárdenas | Almería, Almería, Spain | Recruiting |
| Complejo Hospitalario Universitario de Badajoz | Badajoz, Badajoz, Spain | Recruiting |
| Hospital Sant Joan Despi Moises Broggi | Sant Joan Despí, Barcelona, Spain | Recruiting |
| Hospital General Universitario de Castellón | Castellon, Castellón, Spain | Recruiting |
| Consorcio Hospitalario Provincial de Castellón | Castellon, Castellón, Spain | Recruiting |
| Hospital General Universitario de Ciudad Real | Ciudad Real, Ciudad Real, Spain | Recruiting |
| Hospital Universitario Reina Sofía | Córdoba, Córdoba, Spain | Recruiting |
| Hospital Universitario Donostia | San Sebastián, Gipuzkoa, Spain | Active Not Recruiting |
| Hospital Universitario de Gran Canaria Doctor Negrín | Las Palmas de Gran Canaria, Gran Canaria, Spain | Recruiting |
| Hospital Universitario Principe de Asturias | Alcalá de Henares, Madrid, Spain | Recruiting |
| Hospital Universitario Fundación Alcorcón | Alcorcón, Madrid, Spain | Recruiting |
+ 19 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05250648